Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Updated treatment guidelines for stage IV NSCLC

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Azzoli CG, Baker Jr S, Temin S, Pao W, Aliff T, Brahmer J, Johnson DH, Laskin JL, Masters G, Milton D, Nordquist L, Pfister DG, Piantadosi S, Schiller JH, Smith R, Smith TJ, Strawn JR, Trent D, Giaccone G.American Society of Clinical Oncology Clinical Practice Guideline Update on chemotherapy for stage IV non-small-cell lung cancer. Journal of Clinical Oncology 27: Online first [16 pages], 16 Nov 2009. Available from: URL: http://www.jco.ascopubs.org

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Updated treatment guidelines for stage IV NSCLC. Pharmacoecon. Outcomes News 593, 2 (2009). https://doi.org/10.2165/00151234-200905930-00003

    Download citation

    Keywords

    • Docetaxel
    • Carboplatin
    • Gefitinib
    • Erlotinib
    • Cytotoxic Drug